“The information we have received on Kevetrin is exceptional , especially when viewed with the understanding that Kevetrin is being evaluated in cancer patients with no effective curative or surgical treatment options. The MOA and safety profile will allow us to explore dosing multiple times weekly and combination studies unlike many other drugs, while adding to our optimism that Kevetrin can be a first-in-class drug,”

- See more at: http://cellceutix.com/cellceutixs-clinical-tr...RuW0H.dpuf


This quote should not be swept under the rug. The Management and Scientists behind this who have brought other drugs to a blockbuster status are saying Kevetrin so far is EXCEPTIONAL!